Literature DB >> 3179962

Diagnosis, localization, and management of pheochromocytoma. Pitfalls and follow-up in 41 patients.

N A Samaan1, R C Hickey, P E Shutts.   

Abstract

Forty-one patients who had pheochromocytoma are described. These patients represent the experience of the authors over the last 19 years. The diagnoses, investigations, treatments, and pitfalls of this study and the management of these patients are described. The most sensitive screening test was the urinary measurement of catecholamines, vanillylmandelic acid (VMA), and metanephrines. The most useful localizing procedure was the metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT). After careful alpha and beta adrenergic blockade in 32 patients, no complications occurred during or after tumor resection. When this procedure was ignored even in patients who had normal blood pressure before surgery, severe cardiovascular complications occurred and two patients died. In familial pheochromocytoma, bilateral adrenalectomy with preservation of normal adrenal cortical tissue when possible may be the method of choice, but careful follow-up is warranted.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3179962     DOI: 10.1002/1097-0142(19881201)62:11<2451::aid-cncr2820621134>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

1.  Coexisting extraadrenal pheochromocytoma and von Meyenberg complexes: report of a case.

Authors:  F Tanaka; M Mori; M Haraguchi; N Makino; Y Yoshikawa; T Akiyoshi
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  Risk Stratification in Paragangliomas with PASS (Pheochromocytoma of the Adrenal Gland Scaled Score) and Immunohistochemical Markers.

Authors:  Maithili Mandar Kulkarni; Siddhi Gaurish Sinai Khandeparkar; Sanjay D Deshmukh; R R Karekar; Vandana L Gaopande; Avinash R Joshi; Mrunal V Kesari; R R Shelke
Journal:  J Clin Diagn Res       Date:  2016-09-01

3.  Periureteral pheochromocytoma in a child.

Authors:  I Malcić; I Senecić; D Richter; I Bradić
Journal:  Eur J Pediatr       Date:  1994-11       Impact factor: 3.183

Review 4.  Magnetic resonance imaging or metaiodobenzylguanidine scintigraphy for the demonstration of paragangliomas? Correlations and disparities.

Authors:  A P van Gils; A R van Erkel; T H Falke; E K Pauwels
Journal:  Eur J Nucl Med       Date:  1994-03

5.  Failure of blood pressure control by a new combined alpha- and beta-blocking agent (amosulalol) in a patient with pheochromocytoma.

Authors:  T Yamaguchi; C Irisawa; H Watanabe; S Kawamura; T Nakada
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

6.  [Malignant adrenal pheochromocytoma--problems in evaluating clinical diagnosis and morphologic extent].

Authors:  M Brückner; B C Padberg; M Dürig; S Schröder
Journal:  Langenbecks Arch Chir       Date:  1993

7.  Malignant pheochromocytoma: clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases.

Authors:  M Schlumberger; C Gicquel; J Lumbroso; F Tenenbaum; E Comoy; J Bosq; E Fonseca; P P Ghillani; B Aubert; J P Travagli
Journal:  J Endocrinol Invest       Date:  1992-10       Impact factor: 4.256

8.  Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma.

Authors:  Sara Gonias; Robert Goldsby; Katherine K Matthay; Randall Hawkins; David Price; John Huberty; Lloyd Damon; Charles Linker; Aimee Sznewajs; Steve Shiboski; Paul Fitzgerald
Journal:  J Clin Oncol       Date:  2009-07-27       Impact factor: 44.544

9.  Pheochromocytoma in von hippel-lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2.

Authors:  Christian A Koch; David Mauro; McClellan M Walther; W Marston Linehan; Alexander O Vortmeyer; Ronald Jaffe; Karel Pacak; George P Chrousos; Zhengping Zhuang; Irina A Lubensky
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

10.  Surgical management of pheochromocytoma with the use of metyrosine.

Authors:  R R Perry; H R Keiser; J A Norton; R T Wall; C N Robertson; W Travis; H I Pass; M M Walther; W M Linehan
Journal:  Ann Surg       Date:  1990-11       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.